Donald O'Malley, MD
Orthopedic Surgery · Falmouth, MANPI 1598737090
Payments from drug & device makers
What this record shows
Kairos Surgical Inc accounts for 61.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $789 and has fallen 79.7% since, to $160 in 2025.
Across 17 payments — averaging $77.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$812
- Medacta USA, Inc.$208
- Ferring Pharmaceuticals Inc.$123
- Orthofix Medical, Inc.$92
- Smith+Nephew$48
- Bioventus LLC$38
What the payments were for
- Food & beverage$53140%
- Education$78960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 2 | $812 |
| Medacta USA, Inc. | 2 | $208 |
| Ferring Pharmaceuticals Inc. | 7 | $123 |
| Orthofix Medical, Inc. | 4 | $92 |
| Smith+Nephew | 1 | $48 |
| Bioventus LLC | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIMARY SHOULDER$118
How this compares
$1,320 in reported general payments places this provider in the 80th percentile of 42 orthopedic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 25 | $577 |
| Prednisone | 95 | $384 |
| Meloxicam | 47 | $137 |
| Methylprednisolone | 13 | $78 |
| Tramadol Hcl | 17 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Falmouth
- Amgad AminBoston$195K
- John TierneyDedham$134K
- Zachary BerlinerBoston$14K
- Melissa GrossBoston$13K
- Ivan GolubBoston$7K
- Paul HarasimowiczAyer$4K
- Barry BickleyHaverhill$3K
- Paul PongorMarlboro$2K
- Markian StecykMarlboro$1K
- Mark MessineoNorwood$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.